Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference
Capsida Biotherapeutics ("Capsida"), a leading fully integrated next-generation gene therapy company developing treatments for rare and common diseases across all ages, today announced that the company will present at the 7(th) Annual Evercore HealthCONx Conference being held December 3-5,
Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference
Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of CAR-T cells, today announced that members of management will participate in a fireside chat and 1x1 investor meetings at the 7th Annual Evercore ISI HealthCONx Conference,
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, sees markets in a "digestion phase" following the ...
The Wisconsin-based company reported a same-store sales decline of 9.3% – its eleventh same-store sales decline in a row.
1don MSN
Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss President-elect Trump's nomination ...
Kohl’s surprise CEO departure announcement a day before its quarterly results will play on the minds of investors, who were ...
A live webcast of the Company presentation will be available through the investor relations section of the Company's website at www.akerotx.com. Following the live webcast, an archived replay will be ...
Roger Altman, former deputy Treasury secretary and founder of Evercore, joins CNBC's 'Squawk Box' to discuss president-elect ...
Starting in 2021 an employee hid $132 million to $154 million in delivery expenses, a disclosure overshadowing an otherwise ...
We recently compiled a list of the 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
The retailer said on Monday CEO Tom Kingsbury will step down after less than two years at the helm, and appointed Walmart ...
A month has gone by since the last earnings report for Evercore (EVR). Shares have added about 17.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...
Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...
Evercore ISI analyst Chris McNally maintained a Buy rating on Aptiv (APTV – Research Report) today and set a price target of $105.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback